摘要
Ferid Murad教授是一个出色的同事和导师。我们第一次见面时,他不仅分享了一氧化氮(NO)研究未解决的困惑,也听了我关于蛋白质硝化和亚硝化的问题。这是在我们实验室在研究肿瘤细胞中的信号和基因表达时涉及蛋白质硝化,诱导型一氧化氮合酶和亚硝酸盐的生产的背景下的新的开端。针对细胞膜产生的信号的细胞骨架重构的动态变化由p21活化激酶1(PAK1)调节,p21活化激酶1通过丝氨酸65和丝氨酸128 Tubulin Cofactor B(COB)磷酸化参与微管(MT)动态。在寻找MT的生物合成抵消维护MT动态平衡的机制时,我们探索了TCoB酪氨酸残基硝化的可能性。我们发现TCoB由酪氨酸98和酪氨酸64硝化而来,硝化的TCoB抑制 TCoB的磷酸化。这表明PAK1磷酸化位点是TCoB硝化的必要因素。我们提出了一个模型,其中TCoB硝化作为一种反馈机制,以抵消PAK1信号依赖微管的动态性,从而揭示内在的调节生长因子和一氧化氮在微管的动态信号协调。此外,细胞骨架重构以及导致翻译后修饰的NO的产生是细胞过程的重要修饰物。本文讨论了我与穆拉德教授第一次见面的各项事务相互作用的发展,对NO信号途径在癌症中的作用的共同兴趣以及这些相互作用如何使我们能够连接癌症细胞中的NO Cytoskeleton信号。
关键词: 反射,一氧化氮,激酶信号,PAK1,微管,癌症,GW大学教授
Current Medicinal Chemistry
Title:Reflecting Back to Bring Nitric Oxide Research to the Laboratory
Volume: 23 Issue: 24
Author(s): Rakesh Kumar
Affiliation:
关键词: 反射,一氧化氮,激酶信号,PAK1,微管,癌症,GW大学教授
摘要: Professor Ferid Murad has been a remarkable colleague and a mentor. During our very first meeting, he not only shared unresolved puzzles in Nitric Oxide (NO) research but also listened to my questions pointing to protein nitration and nitrosylation. This was start of a new avenue in my laboratory involving protein nitration, inducible nitric oxide synthase and nitrite production in the context of signaling and gene expression in cancer cells. Dynamic changes in the cytoskeleton remodeling in response to the cell membrane generated signals are regulated by p21-activated kinase 1 (PAK1) which also feed into microtubules (MT) dynamic via phosphorylating Tubulin Cofactor B (CoB) on serine 65 and serine 128. While While searching for the mechanism through which MT biogenesis might be counteracted for the purpose of maintaining the balance in MT dynamic, we explored the possibility of nitration of tyrosine residues in TCoB. We found that TCoB is nitrated on tyrosine 64 and tyrosine 98 and that nitrated TCoB inhibits TCoB phosphorylation and that intact PAK1 phosphorylation sites are also essential for the ability of TCoB to undergo nitration. We suggested a model wherein TCoB nitration acts as a feedback mechanism to counteract PAK1- signaling dependent microtubule dynamics, and thus, revealed an inherent regulatory coordination of growth factor and nitric oxide signaling in microtubule dynamics. In addition, cytoskeleton remodeling and NO production and resulting post-translational modifications in signaling modules serve as important modifiers of cellular processes. Here, I will discuss the cascade of events leading to my first meeting with Professor Murad, the development of scientific interactions, the recognition of our overlapping scientific interests in NO Signaling in cancer cells, and how these interactions have allowed us to connect NO - Cytoskeleton Signaling in cancer cells.
Export Options
About this article
Cite this article as:
Rakesh Kumar , Reflecting Back to Bring Nitric Oxide Research to the Laboratory, Current Medicinal Chemistry 2016; 23 (24) . https://dx.doi.org/10.2174/0929867323666160812150737
DOI https://dx.doi.org/10.2174/0929867323666160812150737 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Targeting Never-In-Mitosis-A Related Kinase 5 in Cancer: A Review
Current Medicinal Chemistry Stressed to Death: Targeting Endoplasmic Reticulum Stress Response Induced Apoptosis in Gliomas
Current Pharmaceutical Design Oxidovanadium(IV) Complex Disrupts Mitochondrial Membrane Potential and Induces Apoptosis in Pancreatic Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Histone Deacetylase Inhibitors: A New Wave of Molecular Targeted Anticancer Agents
Recent Patents on Anti-Cancer Drug Discovery Targeted Tumor Diagnosis and Therapy with Peptide Hormones as Radiopharmaceuticals
Anti-Cancer Agents in Medicinal Chemistry Delivery of Neurotherapeutics Across the Blood Brain Barrier in Stroke
Current Pharmaceutical Design Targeting Transient Receptor Potential Channels in Cardiometabolic Diseases and Myocardial Ischemia Reperfusion Injury
Current Drug Targets MicroRNAs as Regulators in Normal Hematopoietic and Leukemia Stem Cells: Current Concepts and Clinical Implications
Current Molecular Medicine Peptides as Carrier for Tumor Diagnosis and Treatment
Current Medicinal Chemistry - Anti-Cancer Agents Targeting Epidermal Growth Factor Receptor in Solid Tumors: Critical Evaluation of the Biological Importance of Therapeutic Monoclonal Antibodies
Current Medicinal Chemistry Perspectives/Opinion: ADVANCED MEDICAL IMAGING IN THE ERA OF PERSONALIZED OR PRECISION MEDICINE
Current Medical Imaging Pharmacokinetics and Acute Toxicity of a Histone Deacetylase Inhibitor, Scriptaid, and its Neuroprotective Effects in Mice After Intracranial Hemorrhage
CNS & Neurological Disorders - Drug Targets Recent Advances in the Development of Selective CB2 Agonists as Promising Anti-Inflammatory Agents
Current Medicinal Chemistry Application of Metabolomics in Drug Discovery, Development and Theranostics
Current Metabolomics Editorial [Hot Topic: Development of Drugs Interfering with Apoptosis (Executive Guest Editor: Sebastiano Cavallaro)]
Current Pharmaceutical Design Insight to Physiology and Pathology of Zinc(II) Ions and Their Actions in Breast and Prostate Carcinoma
Current Medicinal Chemistry Biomarkers of Angiogenesis and their Role in Patient Selection for Antiangiogenic Therapy
Current Angiogenesis (Discontinued) New Aspects of Regulatory Signaling Pathways and Novel Therapies in Pancreatic Cancer
Current Molecular Medicine The Endocannabinoid System in the Cancer Therapy: An Overview
Current Medicinal Chemistry Presynaptic Cell Dependent Modulation of Inhibition in Cortical Regions
Current Neuropharmacology